Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Journal of Clinical Investigation

• Publication date

  1992-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1172/JCI115645PMID 1541665PMCID PMC442954
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  2004cited by this paper
• Fixed-bin analysis for statistical evaluation of continuous distributions of allelic data from VNTR loci, for use in forensic comparisons.

  1991cited by this paper
• Lipoprotein(a) Levels in Black and White Children and Adolescents With IDDM

  1991cited by this paper
• Decrease of Lipoprotein(a) With Improved Glycemic Control in IDDM Subjects

  1991cited by this paper
• Effects of the apolipoprotein(a) size polymorphism on the lipoprotein(a) concentration in 7 ethnic groups

  1991cited by this paper
• Prevalence of lipoprotein (a) [Lp(a)] excess in coronary artery disease.

  1991cited by this paper
• Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women.

  1991cited by this paper
• Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.

  1991cited by this paper
• A rapid increase in lipoprotein (a) levels after ethanol withdrawal in alcoholic men.

  1991cited by this paper
• Predictive value of lipoprotein (a) and other serum lipoproteins in the angiographic diagnosis of coronary artery disease.

  1990cited by this paper
• Increased serum levels of lipoprotein(a) in diabetes mellitus and their reduction with glycemic control.

  1990cited by this paper
• Lipoprotein (a) and coronary heart disease: a prospective case-control study in a general population sample of middle aged men.

  1990cited by this paper
• Alterations of lipoprotein(a) in patients with diabetic nephropathy.

  1990cited by this paper
• Variation in the size of human apolipoprotein(a) is due to a hypervariable region in the gene

  1990cited by this paper
• Abetalipoproteinemia with an ApoB-100-lipoprotein(a) glycoprotein complex in plasma. Indication for an assembly defect.

  1990cited by this paper
• Polymorphic forms of human apolipoprotein[a]: inheritance and relationship of their molecular weights to plasma levels of lipoprotein[a].

  1990cited by this paper
• Lipoprotein(a) is an independent risk factor for myocardial infarction at a young age.

  1990cited by this paper
• Lipoprotein (a). Heterogeneity and biological relevance.

  1990cited by this paper
• Transient changes of serum lipoprotein(a) as an acute phase protein.

  1989cited by this paper
• Genetics of the quantitative Lp(a) lipoprotein trait

  1989cited by this paper
• Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis.

  1989cited by this paper
• Plasma Ip(a) concentration is inversely correlated with the ratio of Kringle IV/Kringle V encoding domains in the apo(a) gene.

  1989cited by this paper
• The mysteries of lipoprotein(a).

  1989cited by this paper
• Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene.

  1988cited by this paper
• Lp(a) lipoprotein in patients with chronic renal failure treated by hemodialysis.

  1987cited by this paper
• cDNA sequence of human apolipoprotein(a) is homologous to plasminogen

  1987cited by this paper
• Structural relationship of an apolipoprotein (a) phenotype (570 kDa) to plasminogen: homologous kringle domains are linked by carbohydrate-rich regions.

  1987cited by this paper
• Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma.

  1987cited by this paper
• Serum high density lipoprotein cholesterol, apolipoprotein A-I, A-II and B levels in Singapore ethnic groups.

  1987cited by this paper
• The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis. Dependence on serum LDL levels.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for myocardial infarction.

  1986cited by this paper
• Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction.

  1986cited by this paper
• Three alleles for quantitative Lp(a)

  1986cited by this paper
• Genetics of the Lp lipoprotein in Japanese‐Americans

  1985cited by this paper
• The Relationship of Lipoprotein (a) (Lp(a)) to Risk Factors of Coronary Heart Disease: Initial results of the prospective epidemiological study on Company employees in Westfalia

  1984cited by this paper
• The genetics of quantitative plasma Lp(a): analysis of a large pedigree.

  1983cited by this paper
• Complex segregation analysis of the Lp(a)/pre‐ß1‐lipoprotein trait

  1981cited by this paper
• Complex segregation analysis of the Lp(a)/pre-beta 1-lipoprotein trait.

  1981cited by this paper
• Lipoprotein Lp(a) and the risk for myocardial infarction.

  1981cited by this paper
• Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease

  1975cited by this paper
• The genetics of the Lp Antigen

  1974cited by this paper
• Molecular weight determination of protein-dodecyl sulfate complexes by gel electrophoresis in a discontinuous buffer system.

  1971cited by this paper
• CORONARY ARTERY DISEASE Association of levels of lipoprotein Lp ( a ) , plasma lipids , and other lipoproteins with coronary artery disease documented by angiography

  year unknowncited by this paper

• The Lipoprotein(a) rs3798220 and rs10455872 polymorphisms and coronary heart disease: a meta-analysis of 55,647 participants.

  2025cites this paper
• Lipoprotein(a) and Chronic Kidney Disease: Insights into New Therapeutic Opportunities.

  2025cites this paper
• Lipoprotein(a): from Causality to Treatment

  2024cites this paper
• Consensus document on Lipoprotein(a) from the Italian Society for the Study of Atherosclerosis (SISA).

  2023cites this paper
• Lp(a) and the Risk for Cardiovascular Disease: Focus on the Lp(a) Paradox in Diabetes Mellitus

  2022cites this paper
• Mendelian Randomization: Principles and its usage in Lp(a) research.

  2022cites this paper
• Role of Lipoprotein(a) in Cardiovascular Disease: A Review of Clinical Practice

  2022cites this paper
• Lipoprotein(a) and ethnicities.

  2022cites this paper
• The use of blood biomarkers in precision medicine for the primary prevention of atherosclerotic cardiovascular disease: a review

  2021cites this paper
• Lipoprotein(a) as predictor of coronary artery disease and myocardial infarction in a multi-ethnic Asian population.

  2021cites this paper
• Decreased plasma level of lipoprotein lipase predicted verbal disfluency in Chinese type 2 diabetes mellitus patients with early cognitive deficits.

  2021cites this paper
• Elevated Lipoprotein A in South Asians and the Associated Risk of Cardiovascular Disease: A Systematic Review.

  2020cites this paper
• Moving Targets: Recent Advances in Lipid-Lowering Therapies

  2019cites this paper
• LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.

  2018cites this paper
• Is Lp(a) ready for prime time use in the clinic? A pros-and-cons debate.

  2018cites this paper
• LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk.

  2018cites this paper
• LPA kringle IV type 2 is associated with type 2 diabetes in a Chinese population with very high cardiovascular risk[S]

  2018cites this paper
• Human Genetics and the Causal Role of Lipoprotein(a) for Various Diseases

  2016cites this paper
• Structure, function, and genetics of lipoprotein (a)

  2016cites this paper
• Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

  2016cites this paper
• Lipoprotein (a): a historical appraisal

  2016cites this paper
• Lack of association of rs3798220 with small apolipoprotein(a) isoforms and high lipoprotein(a) levels in East and Southeast Asians.

  2015cites this paper
• Impact of lipoprotein(a) levels and apolipoprotein(a) isoform size on risk of coronary heart disease

  2014cites this paper
• Lipoprotein(a): resurrected by genetics

  2013cites this paper
• Update on Lipoprotein(a) as a Cardiovascular Risk Factor and Mediator

  2013cites this paper
• Screening for and Management of Elevated Lp(a)

  2013cites this paper
• Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis

  2012cites this paper
• Age‐related modification of antioxidant enzyme activities in relation to cardiovascular risk factors

  2012cites this paper
• Lipoprotein(a): Reloaded

  2012cites this paper
• Advances in Genetics Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease

  2011cites this paper
• patients with chronic stable angina pectoris Elevated plasma lipoprotein(a) is associated with coronary artery disease in

  2011cites this paper
• Genetic Variants in the Apolipoprotein(a) Gene and Coronary Heart Disease

  2011cites this paper
• Role of apheresis in the management of familial hypercholesterolemia and elevated Lp(a) levels

  2011cites this paper
• Apolipoprotein (a) Isoforms and the Risk of Vascular Disease: A Systematic Review of 40 Studies Involving 58,000 Participants

  2011cites this paper
• concentrations after renal transplantation Apolipoprotein(a) phenotype-associated decrease in lipoprotein(a) plasma

  2011cites this paper
• Lipoprotein(a) and the risk of thromboembolism in Thai children.

  2011cites this paper
• Lipoprotein(a) and ischemic heart disease--a causal association? A review.

  2010cites this paper
• Genetic variants in Lp(a) lipoprotein and coronary disease.

  2010cites this paper
• Genetic variants in Lp(a) lipoprotein and coronary disease.

  2010cites this paper
• Increased burden of coronary artery disease in South-Asians living in North America. Need for an aggressive management algorithm.

  2009influential citation
• Size Matters: The Influence of Isoform Size on the Intracellular Processing of Apolipoprotein(a)

  2009cites this paper
• Plasma lipoprotein (a), homocysteine, and other cardiovascular disease (CVD) risk factors in Nigerians with CVD.

  2008cites this paper
• Elevated Lp(a) with a small apo(a) isoform in children: risk factor for the development of premature coronary artery disease

  2008cites this paper
• Mulficenfer Study of Lipoprotein(a) and Apolipoprotein(a) Phenotypes in Patients With End-Stage Renal Disease Treated by Hemodialysis or Continuous Ambulatory Peritoneal Dialysis1

  2005cites this paper
• The Framingham Heart Study

  2005cites this paper
• RSSDI oration 2003 Why are Indian diabetic subjects more prone to coronary artery disease

  2004cites this paper
• Diet and Plasma Lipoproteins in Elderly With and Without Cardiovascular Disease: Results From the Framingham Heart Study

  2004cites this paper
• Plasma lipoprotein(a) concentration and phenotypes in diabetes mellitus

  2004cites this paper
• Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.

  2004cites this paper
• Significance of apolipoprotein(a) phenotypes in acute coronary syndromes: relation with clinical presentation.

  2004cites this paper
• Why are Indian diabetic subjects more prone to coronary artery disease

  2004cites this paper
• Relationship of lipoprotein(a) with intimal medial thickness of the carotid artery in Type 2 diabetic patients in south India

  2003cites this paper
• Insulin sensitivity and Lp(α) concentrations in normoglycemic offspring of type 2 diabetic parents

  2003cites this paper
• Lipoprotein(a) and prevalent cardiovascular disease in a dialysis population: The Choices for Healthy Outcomes in Caring for ESRD (CHOICE) study.

  2003cites this paper
• Role of lipoprotein(a) in the development of coronary heart disease in patients with essential hypertension

  2003cites this paper
• Lipids in Health and Disease

  2003cites this paper
• Association of Polymorphisms of the Apolipoprotein(a) Gene With Lipoprotein(a) Levels and Myocardial Infarction

  2003cites this paper
• A New Emerging Risk Factor for Cardiovascular Disease: Apo(a) Polymorphism

  2003cites this paper
• Polymorphisms in the Apolipoprotein(a) Gene, Plasma Lp(a) and Cardiovascular Risk

  2003cites this paper
• Lp(a) Particles Mold Fibrin-Binding Properties of Apo(a) in Size-Dependent Manner: A Study With Different-Length Recombinant Apo(a), Native Lp(a), and Monoclonal Antibody

  2002cites this paper
• Medikamentöse und diätetische Therapie der Hyperlipidämie im Kindesalter: Evaluation von Wirksamkeit, Nebenwirkungen und Compliance im Patientenkollektiv der Kinder-Lipidambulanz von 1997-2000

  2002cites this paper
• Apolipoprotein(a) phenotypes predict the severity of coronary artery stenosis.

  2002cites this paper
• [Lipoprotein(a) and Apo-A isoforms in patients with intermittent claudication].

  2002cites this paper
• Effect of ageing on plasma lipoprotein(a) levels

  2002cites this paper
• Correlation of lipoprotein(a) levels and myocardial stress thallium scintigraphy pattern in different entities of CHD severity.

  2002cites this paper
• Stress-induced ST-segment elevation on Q leads after myocardial infarction.

  2001cites this paper
• Lipoprotein (a) and thrombogenesis in left ventricular dysfunction.

  2001cites this paper
• Genetic Effect of Two APOA Repeat Polymorphisms (Kringle 4 and Pentanucleotide Repeats) on Plasma Lp(a) Levels in American Samoans

  2001cites this paper
• Evaluation of Lp[a] and other independent risk factors for CHD in Asian Indians and their USA counterparts.

  2001cites this paper
• Fettstoffwechsel, Übergewicht und Ernährung, Diabetes

  2000cites this paper
• Lipoprotein(a) in atrial fibrillation.

  2000cites this paper
• The Use of a Nonradioactive Digoxigenin Labeled Probe for Detection of Apo(a) Gene Size

  2000cites this paper
• Lipoprotein (a) and thrombogenesis in left ventricular dysfunction

  2000cites this paper
• SIALIC ACID IN LIPOPROTEINS WITH A SPECIAL REFERENCE TO LOW DENSITY LIPOPROTEINS

  2000cites this paper
• Apo(a) isoforms do not predict risk for coronary heart disease in a Gulf Arab population

  2000cites this paper
• Lipoprotein(a), atherosclerosis, and apolipoprotein(a) gene polymorphism.

  2000cites this paper
• LPA gene: interaction between the apolipoprotein(a) size (‘kringle IV’ repeat) polymorphism and a pentanucleotide repeat polymorphism influences Lp(a) lipoprotein level

  2000cites this paper
• Lipoprotein (a) is associated with endothelial function in healthy postmenopausal women.

  2000cites this paper
• Weitere kardiovaskuläre Risikofaktoren

  2000cites this paper
• Pentanucleotide Repeat and Size Polymorphisms in the Apolipoprotein(a) Gene Are Associated with the Lipoprotein(a) Concentration in Chronic Hemodialysis Patients

  1999cites this paper
• Associations among serum lipoprotein(a) levels, apolipoprotein(a) phenotypes, and myocardial infarction in patients with extremely low and high levels of serum lipoprotein(a).

  1999cites this paper
• Identification of megalin/gp330 as a receptor for lipoprotein(a) in vitro.

  1999cites this paper
• Association between apolipoprotein(a) phenotypes and coronary heart disease at a young age.

  1999cites this paper
• Is apolipoprotein(a) a susceptibility gene for Type I diabetes mellitus and related to long-term survival?

  1999cites this paper
• Lipoprotein(a) levels and apolipoprotein(a) isoforms related to life style risk factors.

  1999cites this paper
• [Lipoprotein(a): risk factor for atherosclerotic vascular disease important to take into account in practice].

  1999cites this paper
• Genetic control of lipoprotein(a) concentrations is different in Africans and Caucasians

  1999cites this paper
• The low molecular weight apo(a) phenotype is an independent predictor for coronary artery disease in hemodialysis patients: a prospective follow-up.

  1999cites this paper
• Influence of Lipoprotein (a) Levels and Isoforms on Fibrinolytic Activity – Study in Families with High Lipoprotein (a) Levels

  1998cites this paper
• Inhibition of N-linked glycosylation results in retention of intracellular apo[a] in hepatoma cells, although nonglycosylated and immature forms of apolipoprotein[a] are competent to associate with apolipoprotein B-100 in vitro.

  1998cites this paper
• Intracellular metabolism of human apolipoprotein(a) in stably transfected Hep G2 cells.

  1998cites this paper
• Elevated plasma lipoprotein(a) is associated with coronary artery disease in patients with chronic stable angina pectoris.

  1998cites this paper
• Demonstration of covalent binding of lipoprotein(a) [Lp(a)] to fibrin and endothelial cells.

  1998cites this paper
• Apolipoprotein(a) phenotypes as genetic markers of coronary atherosclerosis severity.

  1998cites this paper
• Association between apolipoprotein(a) polymorphism and Lp(a) levels in Koreans.

  1998cites this paper
• Lipoprotein(a) as a risk factor for coronary artery disease.

  1998cites this paper
• Lipoprotein(a) interactions with lipid and non-lipid risk factors in patients with early onset coronary artery disease: results from the NHLBI Family Heart Study.

  1998cites this paper
• [Lipoprotein (a), a cardiovascular risk factor: importance of its determination in current clinical practice].

  1998cites this paper
• Is lipoprotein(a) an independent risk factor for ischemic heart disease in men? The Quebec Cardiovascular Study.

  1998cites this paper
• Apolipoprotein(a) Phenotypes and Their Predictive Value for Coronary Heart Disease: Identification of an Operative Cut-Off of Apolipoprotein(a) Polymorphism

  1998cites this paper